ANS Pharm: Adrenergic Agonists Flashcards

1
Q

Which vasopressors are removed from the cleft by reuptake? Which aren’t?

A

Dopamine, Epi, Norepi

NOT phenylephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

How is phenylephrine removed from the synapse?

A

metabolized by MAO

This is why MAOIs with phenylephrine = HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which pressors are synethetic noncatecholamine vs endogenous catecholamines?

A

synethetic NONcatecholamine: neosynephrine

endogenous catecholamines: DA, epi, NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The endogenous catecholamines are normally reuptaken via transporters, but what if they escape?

A

metabolized by MAO and COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F:
Both the SNS and PNS are response for fight or flight, as the ANS.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phenylephrine receptor activity

A

selective and direct A1 agonist

sympathomimetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clonidine and Precedex both act ____ to produce sedation, anxiolysis, decrease BP & HR and cause analgesia

A

centrally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classes of drugs that modify the ANS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F:
The SNS and PNS usually work on the same end-organ at the same time.

A

False
usually do not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The ANS relies on these 2 NTs

A

ACh & NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which NTs work at each location?
-ganglionic
-postganglionic PNS
-postganglionic SNS

A

-ganglionic: ACh
-postganglionic PNS: ACh
-postganglionic SNS: NE

ACh is the PNS NT
NE is the SNS NT
(exceptions do exist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

the PNS and SNS of the ANS both target these organs/tissues

A

smooth muscle, cardiac muscle, glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The somatomotor system is part of which nervous system?

A

CNS

somatic motor system: voluntary movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the (PNS/SNS) the ganglion is located closer to the target organ/tissue.

A

PNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which division of the nervous system targets skeletal muscle?

A

Somatomotor system of the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which Alpha selective drug affects Renal blood flow?

A

Neosynephrine; decreases it
(others do not)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are the Alpha selective drugs each metabolized?

A
  • Neo = MAO
  • Clonidine = half life, half kidney UNCHANGED
  • Precedex = Liver CYP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Abruptly stopping which alpha selective agent may cause rebound HTN?

A

clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Phenylephrine is especially useful in …… states

A

low vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Phenylephrine is almost exclusively a pure stimulant at A1 adrenoreceptors, causing….

A

venous AND arterial vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Neo vs. Norepi

A

Neo has similiar effects to NE
but
less potent and longer acting

BOTH risk end-organ damage (high dose/prolonged drip)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why do you see bradycardia with Neo?

A

baroreceptor activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Neo
dosing & gtt

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How does Neo affect pulmonary circulation?

A

Pulmonary artery pressure increases

due to direct vasoconstrictive action of the drug in the lung vasculature and an increase in venous return.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

T/F:
Unlike natural and synthetic catecholamines, phenylephrine is not arrhythmogenic.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

T/F:
The dose of phenylephrine needed to stimulate the a 1 receptor is much more than that for the a2 receptor.

A

False
LESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Sometimes drug like phenylephrine treat the BP number instead of the actual physiological process. When could this happen?

A

hypotensive patient with CAD may increase BP by increasing peripheral vasoconstriction
but
this decreases CO and may worsen ischemia!

(decreased CO is d/t strong baroreceptor reflex (bradycardia) & abrupt increase in afterload)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Phenylephrine overdose

A
  • phentolamine (nonselective A-adrenergic antagonist)
  • or maybe just wait it out since Neo doA is short
  • DO NOT use a Beta blocker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Phenylephrine overdose
What is CONTRAINDICATED?

A

Beta blockers

may induce pulm edema & catastrophic, irreversible CV collapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Where can we find Alpha-2 receptors?

A
  1. Presynaptic: NE-releasing neurons in the CNS and PNS (negative feedback mechanism reduces NE release)
  2. Postsynaptic: Smooth muscle and several organs
  3. Nonsynaptic: platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Alpha-2 receptors by location and their effect

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

The a2 agonists have long been used in treating…

A
  • hypertension
  • ADHD
  • panic disorders
  • drug and alcohol withdrawal
  • sedation
  • sympatholysis
  • reducing anesthetic requirements

these agents can modify the ANS!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Clondine vs. Precedex
A2:A1 binding ratio

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

partial agonist of the A2 receptor

A

clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

T/F:
Clondine can reduce IV anesthetic and volatile requirements.

A

True
but only mild effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

T/F:
Clondine will not cause respiratory depression, but Precedex can.

A

False
neither do

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

clonidine vs. precedex
Where do they act?

A

clonidine: central presynaptic receptors (medulla & locus coeruleus)

precedex: brain and SC; inhibits neuronal firing

both alpha2 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Clonidine & Precedex both block ___ release

A

norepinephrine

this is how clonidine causes vasodilation this way & precedex modifies pain signal propigation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Clonidine
Its central action is its predominant clinical activity. What effects does this have?

A

decreases SNS outflow ➡️ sympatholysis, lowering HR & BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How does clonidine cause centrally induced sedation?

A

via a2 receptors in the locus coeruleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Clonidine produces centrally mediated pain modification and analgesia via …

A

activity at the dorsal horn of the spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Aside from rebound HTN, what can happen when abruptly stopping clonidine?

A

tachycardia and arrhythmia

taper it!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Clonidine has been in use for decades and with demonstrated utility in various conditions:

A
  • diagnosing pheochromocytoma
  • opiate and nicotine withdrawal manifestations
  • HTN

in general, A2 agonists treat
* hypertension
* ADHD
* panic disorders
* drug and alcohol withdrawal
* sedation
* sympatholysis
* reducing anesthetic requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

T/F:
Clonidine’s ANS effects are strong enough that sedative/hypnotic effects can happen in anti-hypertensive doses.

A

True

its action centrally in the locus coeruleus provides the sedative/hypnotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

T/F:
A2 agonists have a distinctive place in anesthesia, partly because of early observations of the effect of clonidine on the ANS.

A

True
patients reported altered pain signals so a2 agonist drug research and development ensued

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

How does Precedex cause hypotension, bradycardia, sedation, and analgesia?

A

Dexmedetomidine stimulates a2 receptors in the brain and spinal cord, leading to inhibition of neuronal firing

decreased sympathetic drive!

dose-dependent sedation, analgesia, and sympatholytic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

T/F:
Dexmedetomidine is a postsynaptic a2 agonist at peripheral receptors.

A

false!
PREsynaptic
CENTRAL receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

T/F:
dexmedetomidine can cause very concerning hypotension and bradycardia, especially with higher and rapid dosing.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Prcedex
Hypertension, tachycardia, and dysrhythmias show us that….

A

a complex distribution of central a2 receptors at which the drug acts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

less appreciated ANS effects of dexmedetomidine

A
  • dry mouth,
  • impaired Gl motility,
  • inhibition of renin release,
  • increased GFR,
  • decreased insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

inhibition of norepinephrine release by dexmedetomidine

A

plays a role in modifying the propagation of pain signals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Dexmedetomidine’s central sympatholytic effect exerts these 2 effects

A
  • anti-shivering
  • overall reduction in the neuroendocrine stress response to surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

T/F:
Precedex can reduce emergence agitation in both adults and children.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

How can Precedex cause transient HTN?

A
  1. Giving Precedex rapidly can stimulate postsynaptic A2 receptors
  2. these receptors are on arterial and venous circulations = vasoconstriction & HTN
  3. CNS effect (vasodilation) lags behind the peripheral response
  4. the CNS effect eventually catches up and overpowers the peripheral effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Which A2 agonist is more protein bound?

A

precedex

Prece loves protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

T/F:
Ephedrine is a non-endogenous direct acting synthetic sympathomimetic.

A

False
indirect acting

non-endogenous & synthetic
noncatecholamine

DA, NE, Epi are endogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Ephedrine
receptor activity & effects

A

stimulates both A & B

myocardial stimulation, bronchodilation, vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

the synthetic catecholamines

A

dobutamine
isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

adverse effects of using endogenous and synthetic catecholamines

A

HTN, arrhthymia and myocardial ischemia

EPI, NE, DA
Isoproterenol, dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

the effects of endogenous and synthetic agonists are dependent on their specificity for which receptors?

A

a-and -adrenoreceptors and dopaminergic subtypes.

61
Q

Appreciating the metabolism of the endogenous catecholamines helps us predict (2)

A

their clinical use and dosing.

62
Q

Epinephrine and norepinephrine metabolism

A

catechol-O-methyl transferase & monoamine oxidase
⬇️
common metabolite, vanilly mandelic acid (VMA)

63
Q

assayed as part of pheochromocytoma work-up

A

vanilly mandelic acid (VMA)

Epi & NE are metbolized to this common metabolite

64
Q

noncatecholamine with both direct and indirect activity at adrenoceptors

65
Q

isoproterenol
vs
dobutamine

A

the synthetic catecholamine isoproterenol has a modified version, dobutamine
both have B1 & some B2 activity

66
Q

Short-and long-acting B2-adrenoceptor agonists

A

short: albuterol
long: salmeterol

asthma, COPD, and airway hyperactivity during anesthesia

67
Q

Dobutamine used more than isoproterenol due to its novel ability to…

A

enhance cardiac contractility and simultaneously reduce arterial vasomotor tone

68
Q

Why give albuterol and salmeterol in aerosolized form?

A

minimizes side effects such
as anxiety, tremor, and restlessness

69
Q

A non-selective adrenergic agonist acts…

A

on BOTH alpha and beta receptors

70
Q

Why do we closely monitor patients on adrenergic agonists?

A

adverse events such as ischemia and arrhythmias

71
Q

adrenergic agonists
can mimic the SNS in 1 of 2 ways

A
  1. direct receptor activation
  2. encourage endogenous catecholamine release
72
Q

Aside from vasoconstriction, what 2 effects can adrenergic agonists give that are clinically desirable?

A
  1. bronchodilation
  2. myocardium stimulation
73
Q

Which adrenergic agonists are metabolized by COMT?

A

entirely: Iso & dobutamine

partially: Epi, NE, DA

74
Q

Which adrenergic agonist will cause the greatest decrease in airway resistance?

A

isoproterenol

lesser extent: Epi & ephedrine
none: NE, DA, dobutamine

75
Q

Which adrenergic agonist will cause the greatest change in renal blood flow?

A

reduces: norepi

increases: dopamine

76
Q

Which agent is best for vasoplegia?

77
Q

Which adrenergic agonist cannot be given as an infusion?

A

ephedrine

Isoproterenol is rapidly metabolized by COMT, so infusion is the preferred route of administration.

78
Q

drug of choice for cardiogenic shock and stress testing

A

dobutamine

80
Q

the prototype sympathomimetic

81
Q

Epi infusion dose

A

0.01 - 0.2 mcg/kg/min

82
Q

Epi receptor activity and effects

A
  • a1, ß1, and B2
  • more potent than norepinephrine at beta
  • potent vasoconstrictor and bronchodilator
  • may cause significant metabolic changes! ↑POCT
  • HypoK due to a transcellular shift
83
Q

The net effect of Epi depends on

A
  1. the balance of the receptor types in the individual tissues and organs
  2. dose
84
Q

Organ response to epi

A
  • more B2r (skeletal muscle): vasodilation
  • more a1r (mesentery, kidneys): vasoconstrict
85
Q

epi
Low dose vs high dose

A
  • Low doses = beta (↑ HR, CO, inotropy, and pulse pressure; ↓SVR)
  • High doses = alpha (↑SVR, ↓CO)
86
Q

Epi is the ideal drug for..

A

anaphylaxis, shock, and ACLS

87
Q

“epinephrine-reversal”

A

A-mediated pressor response
⬇️
B2-mediated depressor response

88
Q

Epi will (reduce/prolong) the doA of locals.

89
Q

should you use Epi to treat hypoTN from A2 blockers??

A

it can but may counterproductive due to “epinephrine-reversal”

A-mediated pressor response becomes B2-mediated depressor response

90
Q

Norepi
receptor activity and effects

A
  • mostly a1 & B; minimal B2
  • minimal metabolic effect; no △POCT
  • △HR may be insignificant; vasoconstriction stimulation of the baroreceptors to slow HR is countered by its B1 positive chronotropic effect.
  • STRONGER systemic vasoconstriction then epi! (ischemia skeletal muscle, bowel, liver, kidney, and cutaneous)
  • ↑ venous return by venous vasoconstriction
91
Q

Are HR changes from Norepi clinically significant?

A

may be insignificant

its vasoconstriction stimulates baroreceptors to slow HR but its countered by its B1 positive chronotropic effect

mostly a1 and B1 effects. It has minimal B2 effects.

92
Q

Norepi IV infusion dose

A

0.01 - 0.22 mcg/kg/min

93
Q

The net effect of NE depends on..

A

the dose

epi net effect depends on both dose and organ’s receptors

94
Q

Hgih vs low dose Norepi

A

Low: B1 (↑ HR, CO, inotropy, dromotropy)

High: B1 & A (↓HR, systemic constriction, except for the coronary arteries)

dromotropy: conduction speed

95
Q

T/F:
Epinephrine causes greater systemic vasoconstriction than Norepi.

A

False
opposite

96
Q

T/F:
High doses of Norepi will cause systemic vasoconstriction including coronary arteries.

A

False!
the coronaries are spared

Low: B1 (↑ HR, CO, inotropy, dromotropy)

High: B1 & A (↓HR, systemic constriction, except for the coronary arteries)

97
Q

NE’s principal use

A
  • ↑ total peripheral vascular resistance ➡️ ↑BP
  • first-line therapy in distributive shock refractory to hypotension
98
Q

Norepinephrine is a double-edged sword as its potent vasoconstriction risks (2)

A

volume depletion
&
ischemia to bowel, kidneys, liver

99
Q

Dopamine receptor activity
by dose range

A
  • Low (< 3 ug/kg/min): D1 (dilation, ↑ renal & splanchnic flow)
  • Moderate (3 - 8 ug/kg/min): a1 & B1 in the heart & periphery (↑ contractility & BP)
  • High (> 10 ug/kg/min): pure a1 agonist → BP
100
Q

DA’s complex functionality

A

wide range of dopaminergic & adrenergic receptors

101
Q

How does dopamine increase CO?

A

positive chronotropic, inotropic, and dromotropic activity via B1

102
Q

The dose-response to DA varies widely in the general population due to

A

genetics, individual pharmacokinetic differences, and comorbidity.

103
Q

Types of dopamine receptors

A
  • Postsynaptic D1: dilate renal, Gl, coronary, and cerebral
  • Presynaptic D2: inhibit norepi release = dilate
  • D2: pituitary gland, emetic center, kidney
104
Q

What causes Dopamine’s highly variable effect on different vascular beds ?

A

depends on dose used, receptor type & density on the vessels

105
Q

Rapid metabolism of ___ necessitates administration as an infusion.

106
Q

DA has a useful & unique clinical effect to increase contractility and BP while increasing renal blood flow and urine output
but…

A

“Renal dose dopamine”/renal-protective effects are highly variable and largely unproven

107
Q

T/F:
Dopamine may the prevent but not reverse acute kidney injury or failure.

A

False
the data are conclusive that dopamine does not prevent or reverse acute kidney injury or failure.

108
Q

Due to unlikely benefit and the potential for these adverse effects, using dopamine to protect the kidneys should be abandoned

A

evidence that low-dose dopamine can be associated with CV, pulmonary, Gl, immune, and endocrine complications

109
Q

Why is Renal-dose dopamine a thing even though its not proven?

A
  • evidence of low dose infusions (< 3 ug/kg/min) increasing renal blood flow & urine output in healthy ppl
  • dopamine increases renal blood flow via D1r & inhibits D2r norepi release
  • people to try to apply this to renal patients & those at risk of decreased renal blood flow due to anesthesia or surgery
110
Q

How are Epi and Norepi metabolized into vanilly mandelic acid?

111
Q

Dopamine undergoes similar mechanisms (to epia nd norepi) of metabolic degradation by COMT and MAO. The end-product of DA metabolism is

A

homovanillic acid (HVA)

112
Q

B3 receptors
locations & effects

A

primarily in adipose tissue

thermoregulation and lipolysis
but
effects of catecholamines stimulation are unclear

113
Q

Non-selective Adrenergic Agonists: Synthetic Catecholamines

A

ISOPROTERENOL
DOBUTAMINE

114
Q

T/F:
Dopamine is derived from Isoproterenol.

A

FALSE
Isoproterenol is derived from dopamine.

Dobutamine is derived from isoproterenol.

115
Q

Isoproterenol
IV infusion dose

A

0.015 - 0.15 mcg/kg/min

*Barash 8th edition incorrectly states the dose of isoproterenol as 2 - 10 mcg/kg/min.

116
Q

describe the potency of Isoproterenol

A

potent sympathomimetic with 1 and 2 activity.

2 - 3 times the potency of epinephrine and has no A activity.

117
Q

Isoproterenol
she used to be popular but…

A
  • was viewed as ideally suited to increase HR in those patients with heart block
  • It tends to precipitate supraventricular and ventricular arrhythmias
  • largely been replaced by transcutaneous or transvenous pacing

limited clinical use.

118
Q

Isoproterenol
uses

A

right ventricular dysfunction and pulmonary congestion

though NO and prostaglandin I2 are more effective with fewer side effects.

119
Q

For the most part, these agents have replaced isoproterenol as bronchodilators.

A

selective B2 agonists

120
Q

Isoproterenol is rapidly metabolized by ___, so infusion is the preferred route of administration.

121
Q

In terms of the adrenergic agonists, who’s derived from who?

A

Dopamine
⬇️
isoproterenol
⬇️
dobutamine

122
Q

Dobutamine
drip dose

A

2 - 20 mcg/kg/min

123
Q

acts as a “pharmacological stress test”

A

Dobutamine

Chemical pacing with dobutamine is used in place of the patient exercising - this procedure illustrates how dobutamine affects the ANS.

124
Q

Dobutamine is now less commonly used in cardiac surgery because

A

extending a cardiac infarction
&
increasing AV conduction (may turn AFIB into AFIB w/ RVR)

125
Q

Dobutamine
receptor activity & effects

A
  • synthetic, selective B1 agonist with some mild B2 effects
  • ↑ HR & inotropy
  • inotropic agent for pulmonary HTN as it decreases pulmonary arterial pressures & vascular resistance via B2
126
Q

When to use dobutamine

A
  • inotropic agent for pulmonary HTN as it decreases pulmonary arterial pressures & vascular resistance via B2
  • organic heart disease, MI, and depressed myocardial states
127
Q

Ephedrine exerts both direct and indirect actions on adrenoceptors with ___ actions predominating.

128
Q

ephedrine
IV & IM dose

A

IV dose = 5 -25 mg
IM dose = up to 50 mg.

129
Q

Ephedrine
direct vs indirect action

A

direct: both a and & receptors
direct B2 limits the increase in BP from a1-adrenoceptor activation

indirect: Norepi release
1. endocytosis of ephedrine into adrenergic presynaptic terminals
1. displaces norepi from secretory vesicles
1. NE activates A1 & B1 as usual

130
Q

Ephedrine Tachyphylaxis

A

repeat administrations

deplete presynaptic norepi
so ephedrine is released from synaptic vesicles as a false neurotransmitter instead

131
Q

T/F:
Ephedrine is not given as an infusion due to its metabolism.

A

False
tachyphylaxis

repeat administrations

deplete presynaptic norepi
so ephedrine is released from synaptic vesicles as a false neurotransmitter instead

132
Q

T/F:
Ephedrine has potential for abuse.

A

True
It crosses the BBB with mild stimulating effects that may invite misuse

133
Q

Ephedrine is typically dosed as a bolus, which onsets rapidly and may have a duration of

A

up to an hour based on the dose

134
Q

T/F:
Ephedrine does not produce clinically worrisome hyperglycemia like epinephrine.

135
Q

Ephedrine’s effects are less pronounced and more prolonged than those of ___

A

epinephrine

136
Q

Ephedrine vs Neo
OB

A
  • Ephedrine was long preferred due to incorrect concerns about decreasing uterine blood flow
  • Neo may now be preferable in treating anesthetic-induced hypotension in the parturient.
137
Q

Ephedrine has multiple actions (positive inotropy and chronotropy). Who may this not be good for?

A

can increase 02 demand in those with coronary artery disease

138
Q

Phenylephrine is structurally like ephedrine except that….

A

phenylephrine possesses a 4-hydroxyl group on the benzene ring

139
Q

phenylephrine is almost purely ___-selective.

140
Q

Beta-2 agonists are classified by doA
What are the classes?

A

short: albuterol, terbutaline, levalbuterol.

Long: salmeterol and formoterol

141
Q

Pros and Cons of
Aerosolized B2-selective agents

A

bronchodilation and minimize cardiac stimulation/arrhythmias
but
pure B2 selectivity does not occur!

142
Q

How do B2-selective drugs duplicate the functionality of the endogenous catecholamines on the ANS?

A

help to isolate the effect on the smooth muscle of the airway, uterus, GI tract, and systemic vasculature

143
Q

___ properties of drugs such as albuterol and salmeterol are of primary value in our perioperative care of the patient

A

bronchodilatory

144
Q

Chronic B agonist therapy

A
  • may lead to receptor down-regulation = tachyphylaxis
  • evidence of airway hyperresponsiveness
  • chronic high doses: B2 selectivity wanes, and B1 effects such as tachycardia and arrhythmias may become apparent
145
Q

Beta-2 agonists moA

A

increased intracellular cAMP

in uterine muscle, ↑cAMP = ↓Ca = uterine smooth muscle relaxation & tocolytic effect

146
Q

Which Beta-2 agonists have a black box warning? why?

A

longer-acting agents; risk of asthma-related death

reports of severe asthma exacerbations in some patients using salmeterol and formoterol, possibly from developing airway hyperresponsiveness

147
Q

What potent alpha agonist is the chemical precursor of epinephrine?

A

Norepi

precursor of norepi = dopamine

148
Q

Which adrenoreceptor agonist is metabolized by the liver?

149
Q

Would epi or norepi give you the greatest increase in MAP?

150
Q

Ephedrine metab

A

liver

  • oxidative deamination
  • demethylation
  • aromatic hydroxylation
  • conjugation

Metabolites: norepi & benzoic acid

Unlike the endogenous catecholamines, it is resistant to MAO & COMT.